Infliximab-induced pericarditis can occur through the following mechanisms: direct cardiac toxicity, IgE-mediated allergic reaction, humoral antibody response, cell-mediated hypersensitivity, or serum sickness-like reaction, and drug-induced lupus. The gene discussed is IGHE; the disease is pericarditis.